Hydroxychloroquine Sulfate Hydroxychloroquine Sulfate 200 MG Oral Tablet
INDICATIONS Hydroxychloroquine sulfate is indicated for the suppressive treatment and treatment of acute attacks of Malaria due to Plasmodium vivax, P. Malariae, P. ovale, and susceptible strains of P. falciparum . It is also indicated for the treatment of discoid and systemic Lupus erythematosus, and Rheumatoid Arthritis.
Sandoz Inc
ROUND WHITE Gg 260
Gg 260 ROUND WHITE
Related Pills
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED Hydroxychloroquine sulfate tablets, USP for oral administration are available as: 200 mg: round, off white tablets, scored and debossed GG 260 on one side and plain on the reverse side, film coated white and supplied as: NDC 0781-1407-01 bottles of 100 NDC 0781-1407-05 bottles of 500 NDC 0781-1407-10 bottles of 1000 Each tablet contains 200 mg hydroxychloroquine sulfate (equivalent to 155 mg base). Store at 20°-25°C (68°-77°F) (see USP Controlled Room Temperature). Dispense in a tight, light-resistant container.
More pills like ROUND Gg 260